Steroids are part of rescue therapy in ARDS patients with refractory hypoxemia: no

Intensive Care Medicine

Volumn 42, Issue 5, 2016, Pages 921-923

  Thompson, B Taylor ^a   Ranieri, V Marco ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; OXYGEN; STEROID;

ADULT RESPIRATORY DISTRESS SYNDROME; AIRWAY PRESSURE; ARTERIAL OXYGEN TENSION; ARTIFICIAL VENTILATION; COMMUNITY ACQUIRED PNEUMONIA; CORTICOSTEROID THERAPY; EDITORIAL; HUMAN; HYPERVOLEMIA; HYPOXEMIA; LUNG FUNCTION; META ANALYSIS (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); SEPSIS; HYPOXIA; RESPIRATORY DISTRESS SYNDROME, ADULT;

HUMANS; HYPOXIA; RESPIRATORY DISTRESS SYNDROME, ADULT; STEROIDS;

EID: 84958775003     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-016-4255-1     Document Type: Editorial

References (15)

1. Coombes A, Ranieri M (2015) Rescue therapy for refractory ARDS should be offered early: yes. Intensive Care Med 41:923–925
2. Brodie D, Guerin C (2015) Rescue therapy for refractory ARDS should be offered early: no. Intensive Care Med 41:926–929
3. Roch A, Papazian L (2015) Rescue therapy for refractory ARDS should be offered early: we are not sure. Intensive Care Med 41:930–932
4. Gibelin A, Parrot A, Maitre B et al (2016) Acute respiratory distress syndrome mimickers lacking common risk factors of the Berlin definition. Intensive Care Med 42(2):164–172. doi: 10.1007/s00134-015-4064-y
5. Allen J, Pacht E, Gadek J et al (1989) Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med 321:569–574
6. Gagnon S, Boota AM, Fischl MA et al (1990) Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 323:1440–1450
7. Kallenberg CG (2015) Pathogenesis and treatment of ANCA-associated vasculitides. Clin Exp Rheumatol 33[4 Suppl 92]:S11–S14
8. Peter J, John P, Graham P, Moran J, Abraham I, Bersten A (2008) Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ 336:1006–1009
9. Meduri GU, Bridges L, Shih MC, Marik PE, Siemieniuk RA, Kocak M (2015) Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients’ data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med. doi: 10.1007/s00134-015-4095-4
10. Hough C (2014) Steroids for acute respiratory distress syndrome? Clin Chest Med 357:781–795
11. Meduri G, Chinn A, Leeper R et al (1994) Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of corticosteroid rescue treatment of progressive. Chest 105:1516–1527
12. Steinberg K, Hudson L, Goodman R et al (2006) Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354:1671–1684
13. Blum C, Nigro N, Briel M et al (2015) Adjunct prednisone therapy for patients with community acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 385:1511–1518
14. Torres A, Sibila O, Ferrer M et al (2015) Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA 313(7):677–686
15. Sprung C, Annane D, Keh D et al (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358:111–124